| Author | Heringer, Gustavo Carlos | |
| Author | Oueghlani, Evelyne | |
| Author | Dell’Omo, Roberto | |
| Author | Curi, André Luiz Land | |
| Author | Oréfice, Fernando | |
| Author | Pavésio, Carlos E. | |
| Access date | 2015-07-10T13:31:46Z | |
| Available date | 2015-07-10T13:31:46Z | |
| Document date | 2014 | |
| Citation | HERINGER, Gustavo Carlos et al. Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy. British Journal of Ophthalmology, v. 98, n.9, p.1218-1220, 2014. | pt_BR |
| ISSN | 0007-1161 | |
| URI | https://www.arca.fiocruz.br/handle/icict/11208 | |
| Sponsorship | The research was supported by the National Institute for Health Research
(NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS
Foundation Trust and UCL Institute of Ophthalmology. The views expressed are
those of the author(s) and not necessarily those of the NHS, the NIHR or the
Department of Health. | pt_BR |
| Language | eng | pt_BR |
| Publisher | BMJ Publishing Group | pt_BR |
| Rights | restricted access | pt_BR |
| Title | Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy | pt_BR |
| Type | Article | |
| DOI | 10.1136/bjophthalmol-2013-304259 | |
| Abstract | BACKGROUND/AIMS: Toxoplasmic retinochoroiditis is the commonest known cause of posterior uveitis worldwide and reactivation is unpredictable. Based on results from one study, the authors proposed that antitoxoplasmic therapy should be initiated as prophylaxis for intraocular surgery in patients with toxoplasmic scars. The aim of this study is to analyse the risk of toxoplasmic retinochoroiditis reactivation following intraocular procedures. METHODS: Retrospective analysis of the medical records of a total of 69 patients who underwent intraocular surgery and presented with toxoplasmic retinochoroiditis scars. RESULTS: No patient received prophylactic antitoxoplasmic therapy. Reactivation following the surgical procedure occurred in four cases, with one at 3 months and the others respectively at 13, 14 and 17 months.
CONCLUSIONS:
Our study shows that intraocular surgery did not result in a significant reactivation rate of toxoplasmic retinochoroiditis in the absence of preoperative prophylactic antitoxoplasmic therapy.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. | pt_BR |
| Affilliation | Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil. | pt_BR |
| Affilliation | Moorfields Eye Hospital. London, UK. | pt_BR |
| Affilliation | Moorfields Eye Hospital. London, UK. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil | pt_BR |
| Affilliation | Universidade Federal de Minas Gerais. Belo Horizonte, MG, Brasil. | pt_BR |
| Affilliation | Moorfields Eye Hospital. London, UK. | pt_BR |
| Subject | Infection | pt_BR |
| Subject | Inflammation | pt_BR |
| Subject | Eye/immunology | pt_BR |
| Subject | Acquired Immunodeficiency Syndrome | pt_BR |
| DeCS | Infecção | pt_BR |
| DeCS | Inflamação | pt_BR |
| DeCS | Olho/imunologia | pt_BR |
| DeCS | Síndrome de Imunodeficiência Adquirida | pt_BR |
| e-ISSN | 1468-2079 | |
